APA (7th ed.) Citation

A, D., D, R., V, M., L, M., C, M., G, D., & C, D. (2023). Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma. Frontiers in oncology, 13, 1110916. https://doi.org/10.3389/fonc.2023.1110916

Chicago Style (17th ed.) Citation

A, Domenger, Ricci D, Mayau V, Majlessi L, Marcireau C, Dadaglio G, and Demangel C. "Sec61 Blockade Therapy Overrides Resistance to Proteasome Inhibitors and Immunomodulatory Drugs in Multiple Myeloma." Frontiers in Oncology 13 (2023): 1110916. https://doi.org/10.3389/fonc.2023.1110916.

MLA (9th ed.) Citation

A, Domenger, et al. "Sec61 Blockade Therapy Overrides Resistance to Proteasome Inhibitors and Immunomodulatory Drugs in Multiple Myeloma." Frontiers in Oncology, vol. 13, 2023, p. 1110916, https://doi.org/10.3389/fonc.2023.1110916.